Lorri L. Short

1.2k total citations
18 papers, 1.0k citations indexed

About

Lorri L. Short is a scholar working on Genetics, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lorri L. Short has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 5 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lorri L. Short's work include Estrogen and related hormone effects (14 papers), Menopause: Health Impacts and Treatments (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Lorri L. Short is often cited by papers focused on Estrogen and related hormone effects (14 papers), Menopause: Health Impacts and Treatments (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Lorri L. Short collaborates with scholars based in United States and Singapore. Lorri L. Short's co-authors include Andrew L. Glasebrook, Masahiko Sato, David E. Magee, Henry U. Bryant, Diane L. Phillips, H.U. Bryant, Harlan W. Cole, Pamela K. Shetler, Steven H. Zuckerman and Timothy A. Grese and has published in prestigious journals such as Endocrinology, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Lorri L. Short

18 papers receiving 978 citations

Peers

Countries citing papers authored by Lorri L. Short

Since Specialization

Citations

This map shows the geographic impact of Lorri L. Short's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorri L. Short with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorri L. Short more than expected).

Fields of papers citing papers by Lorri L. Short

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorri L. Short. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorri L. Short. The network helps show where Lorri L. Short may publish in the future.

Co-authorship network of co-authors of Lorri L. Short

This figure shows the co-authorship network connecting the top 25 collaborators of Lorri L. Short. A scholar is included among the top collaborators of Lorri L. Short based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorri L. Short. Lorri L. Short is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Photochemical Synthesis of N-Arylbenzophenanthridine Selective Estrogen Receptor Modulators (SERMs) 2001 ·Journal of Medicinal Chemistry ·Timothy A. Grese, Mary D. Adrian, Diane L. Phillips, Pamela K. Shetler, Lorri L. Short, Andrew L. Glasebrook, Henry U. Bryant	18
2	Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators 1998 ·Journal of Medicinal Chemistry ·Timothy A. Grese, Lewis D. Pennington, James P. Sluka, Mary D. Adrian, Harlan W. Cole, (unknown), David E. Magee, Diane L. Phillips, Ellen R. Rowley, Pamela K. Shetler, Lorri L. Short, Murali Venugopalan, Na Yang, Masahiko Sato, Andrew L. Glasebrook, Henry U. Bryant	118
3	Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene 1997 ·Journal of Medicinal Chemistry ·Timothy A. Grese, (unknown), (unknown), Alexander G. Godfrey, Charles D. Jones, Charles W. Lugar, Michael J. Martin, Ken Matsumoto, Lewis D. Pennington, Mark A. Winter, Mary D. Adrian, Harlan W. Cole, David E. Magee, Diane L. Phillips, Ellen R. Rowley, Lorri L. Short, Andrew L. Glasebrook, Henry U. Bryant	152
4	Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator 1997 ·Journal of Medicinal Chemistry ·Alan D. Palkowitz, Andrew L. Glasebrook, K. Jeff Thrasher, Kenneth L. Hauser, Lorri L. Short, Diane L. Phillips, (unknown), Masahiko Sato, Pamela K. Shetler, George J. Cullinan, (unknown), Henry U. Bryant	144
5	ChemInform Abstract: Discovery and Synthesis of [6‐Hydroxy‐3‐[4‐[2‐(1‐piperidinyl)ethoxy]phenoxy]‐ 2‐(4‐hydroxyphenyl)]benzo[b]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator. 1997 ·ChemInform ·Alan D. Palkowitz, Andrew L. Glasebrook, K. Jeff Thrasher, Kenneth L. Hauser, Lorri L. Short, Diane L. Phillips, (unknown), Masahiko Sato, Pamela K. Shetler, George J. Cullinan, (unknown), H.U. Bryant	2
6	Versatile raloxifene triflates 1997 ·Bioorganic & Medicinal Chemistry Letters ·Michael J. Martin, Timothy A. Grese, Andrew L. Glasebrook, Ken Matsumoto, Lewis D. Pennington, Diane L. Phillips, Lorri L. Short	9
7	Rapid tumor development with a modified MCF-7 xenograft model. 1997 ·PubMed ·Laura V. Hale, (unknown), Paul Wilson, Lorri L. Short, (unknown), (unknown), Robin Fuchs‐Young	3
8	Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity 1997 ·The Journal of Steroid Biochemistry and Molecular Biology ·Jeffrey A. Dodge, Charles W. Lugar, (unknown), Lorri L. Short, Masahiko Sato, Na Yang, Larry A. Spangle, Michael J. Martin, (unknown), Andrew L. Glasebrook, John J. Osborne, Charles A. Frolik, Henry U. Bryant	47
9	Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·Jeffrey A. Dodge, Andrew L. Glasebrook, David E. Magee, (unknown), Masahiko Sato, Lorri L. Short, (unknown)	123
10	The Effect of a Selective Estrogen Receptor Modulator on the Progression of Spontaneous Autoimmune Disease in MRLlpr/lprMice 1996 ·Cellular Immunology ·L D Apelgren, Dale L. Bailey, (unknown), Lorri L. Short, (unknown), Glenn F. Evans, George E. Sandusky, Steven H. Zuckerman, Andrew L. Glasebrook, Thomas F. Bumol	34
11	Estriol: A potent regulator of TNF and IL-6 expression in a murine model of endotoxemia 1996 ·Inflammation ·Steven H. Zuckerman, Susanne E. Ahmari, (unknown), Glenn F. Evans, Lorri L. Short, Andrew L. Glasebrook	42
12	Synthesis and pharmacology of 2-alkyl raloxifene analogs 1996 ·Bioorganic & Medicinal Chemistry Letters ·Timothy A. Grese, (unknown), Henry U. Bryant, Harlan W. Cole, Andrew L. Glasebrook, David E. Magee, Diane L. Phillips, Ellen R. Rowley, Lorri L. Short	10
13	Conversion of the phytoestrogen coumestrol into a selective estrogen receptor modulator (SERM) by attachment of an amine-containing sidechain 1996 ·Bioorganic & Medicinal Chemistry Letters ·Timothy A. Grese, Harlan W. Cole, David E. Magee, Diane L. Phillips, (unknown), Lorri L. Short, (unknown), Henry U. Bryant	5
14	A role for CD8+ T lymphocytes in osteoclast differentiation in vitro. 1996 ·Endocrinology ·Vanchit John, Janet M. Hock, Lorri L. Short, Andrew L. Glasebrook, R. Galvin	73
15	In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. 1995 ·PubMed Central ·Steven H. Zuckerman, (unknown), Glenn F. Evans, Lorri L. Short, Andrew L. Glasebrook	55
16	Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor 1995 ·Annals of the New York Academy of Sciences ·Robin Fuchs‐Young, (unknown), Lorri L. Short, Michael W. Draper, Marian K. Rippy, Harlan W. Cole, David E. Magee, John D. Termine, H.U. Bryant	70
17	Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Masahiko Sato, (unknown), Lorri L. Short, Charles W. Slemenda, H.U. Bryant	100
18	Relevance of Protein Binding to Cephalosporin Antimicrobial Activity in vivo 1990 ·Chemotherapy ·(unknown), Lorri L. Short, M J Hershman, William G. Cheadle	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact